GTS Securities’s Boston Scientific BSX Stock Holding History

GTS Securities’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-20,000	Closed	-$1.68M	–	1631
2024 Q3	$1.68M	Sell	20,000 -1,400	-7%	-$110K	﹤0.01%	1699
2024 Q2	$1.65M	Sell	21,400 -2,500	-10%	-$183K	﹤0.01%	1661
2024 Q1	$1.64M	Sell	23,900 -18,500	-44%	-$1.19M	﹤0.01%	1608
2023 Q4	$2.45M	Sell	42,400 -16,600	-28%	-$886K	﹤0.01%	1510
2023 Q3	$3.12M	Buy	+59,000	New	+$3.09M	0.01%	1212

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GTS Securities's BSX Position: Q1 2026 in Review

GTS Securities reduced its Boston Scientific (BSX) stake by 50% in Q1 2026, selling an estimated $557K and leaving 6,962 shares worth $437K. The position accounts for 0.02% of the portfolio, ranked #834.

GTS Securities first reported a position in BSX in Q3 2023 and has held it in 10 quarters since. The position peaked at $6.86M in Q3 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

GTS Securities held 6,962 shares of Boston Scientific worth $437K as of Q1 2026.
GTS Securities sold 6,968 Boston Scientific shares in Q1 2026, an estimated $557K.
Boston Scientific made up 0.02% of GTS Securities's portfolio in Q1 2026, its #834 holding.
GTS Securities first reported a position in Boston Scientific in Q3 2023 and has held it in 10 quarters since.
GTS Securities's Boston Scientific position peaked at $6.86M in Q3 2024.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.